AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.
종목 코드 RCEL
회사 이름AVITA Medical Inc
상장일Mar 18, 2012
CEOVance (Cary G)
직원 수260
유형Ordinary Share
회계 연도 종료Mar 18
주소28159 Avenue Stanford
도시VALENCIA
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호91355
전화16613679170
웹사이트https://www.avitamedical.com/
종목 코드 RCEL
상장일Mar 18, 2012
CEOVance (Cary G)
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음